Reza Kianmanesh is an expert in Surgery at University of Reims Champagne-Ardenne (France). Reza Kianmanesh has authored 314 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 753 (community average: 125). How the SLR is computed.

LeadR Profile

753 ScienceLeadR Reputation 753
Network Map

Surgery

Subspecialties: Oncology - Hepatology - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026

Source: PubMed

University of Reims Champagne-Ardenne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 314

Citations

Citations: 19 212 1st author: 18 Last author: 61 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
R1 Vascular Margins in Minimally Invasive Liver Surgery: Absence of Evidence is Not Evidence of Equivalence.
PMID 41795052 — absenteeism, liver
Ann Surg Oncol20260
The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.
PMID 41576516 — neoplasms, hyperthermic intraperitoneal chemotherapy, propensity score, drug therapy, neoplasm metastasis, therapeutics, laparotomy, chemotherapy
Eur J Surg Oncol20260
Simultaneous Abdominal Wall Reconstruction and Panniculectomy in High-Risk Complex Patients: A Retrospective Cohort Study.
PMID 41480238 — hernia, cohort studies, classification, hernia, ventral, morbidity, herniorrhaphy
J Abdom Wall Surg20250
Hepatectomy for oligometastatic liver disease in oesophageal adenocarcinoma: The METHEOR study.
PMID 41242088 — liver diseases, progression-free survival, adenocarcinoma, drug therapy, liver, hepatectomy, neoplasm metastasis, therapeutics, chemotherapy
Eur J Surg Oncol20250
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients.
PMID 41006791 — cytoreduction surgical procedures, hyperthermia, induced, mesothelioma, hyperthermic intraperitoneal chemotherapy, drug therapy, chemotherapy
Ann Surg Oncol20250

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6
Phase 2 1
Phase 3 1

By status:

Completed 5
Recruiting 2
Unknown 1

By type:

Interventional 4
Observational 4

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 8

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases
NCT04163887 — neoplasms, colon, laparoscopy, liver, hepatectomy, liver neoplasms, neoplasm metastasis, postoperative complications, colonic neoplasms
N/ARecruiting2021

LeadR Networks

Main global connection map